Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454361 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability and Pharmacokinetics of KBP-7072
A Phase 1 study, sponsored by KBP Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT02454361 is a Phase 1 study that has completed, run by KBP Biosciences. The registered enrollment target is 46 participants.
The verdict
NCT02454361, a Phase 1 study, has completed, sponsored by KBP Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled, dose-escalation study to evaluate the safety, tolerability and pharmacokinetics of a single dose of KBP-7072 following oral single ascending dose administration and with an open label food effect panel.
Interventions
- DRUG Placebo
- DRUG KBP-7072
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02454361
The ClinicalTrials.gov registry entry for NCT02454361 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is KBP Biosciences, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02454361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02454361 about?
NCT02454361 is a clinical study titled "Safety, Tolerability and Pharmacokinetics of KBP-7072". This is a randomized, double-blind, placebo-controlled, dose-escalation study to evaluate the safety, tolerability and pharmacokinetics of a single dose of KBP-7072 following oral single ascending dose administration and with an open label food effect panel.
What is the current status of trial NCT02454361?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2015-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02454361?
The interventions under investigation include: Placebo (DRUG), KBP-7072 (DRUG).
Who is sponsoring clinical trial NCT02454361?
This trial is sponsored by KBP Biosciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.